Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Warnock

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2013
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKDLynae J Hanks, Rikki M Tanner, Paul Muntner, et al.
Preventing Chronic Disease|March 17, 2006
Chronic kidney disease: a public health problem that needs a public health action planAnton C Schoolwerth, Michael M Engelgau, Thomas H Hostetter, et al.
Plos One|May 11, 2012
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry diseaseAurelie Nguyen Dinh Cat, Brigitte Escoubet, Vincent Agrapart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2015
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) StudyHolly Kramer, Orlando M Gutiérrez, Suzanne E Judd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2009
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapyRaphael Schiffmann, David G Warnock, Maryam Banikazemi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2011
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) StudyHolly Kramer, David Shoham, Leslie A McClure, et al.
Plos One|August 13, 2013
High-sensitivity C-reactive protein and risk of sepsisHenry E Wang, Nathan I Shapiro, Monika M Safford, et al.
Journal of Medical Genetics|September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry diseaseIvan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participantsDeidra C Crews, William M McClellan, David A Shoham, et al.
Kidney International|December 18, 2014
Obesity, metabolic health, and the risk of end-stage renal diseaseBhupesh Panwar, Lynae J Hanks, Rikki M Tanner, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2013
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKDLynae J Hanks, Rikki M Tanner, Paul Muntner, et al.
Preventing Chronic Disease|March 17, 2006
Chronic kidney disease: a public health problem that needs a public health action planAnton C Schoolwerth, Michael M Engelgau, Thomas H Hostetter, et al.
Plos One|May 11, 2012
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry diseaseAurelie Nguyen Dinh Cat, Brigitte Escoubet, Vincent Agrapart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 19, 2015
Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) StudyHolly Kramer, Orlando M Gutiérrez, Suzanne E Judd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 17, 2009
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapyRaphael Schiffmann, David G Warnock, Maryam Banikazemi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2011
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) StudyHolly Kramer, David Shoham, Leslie A McClure, et al.
Plos One|August 13, 2013
High-sensitivity C-reactive protein and risk of sepsisHenry E Wang, Nathan I Shapiro, Monika M Safford, et al.
Journal of Medical Genetics|September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry diseaseIvan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 15, 2012
Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participantsDeidra C Crews, William M McClellan, David A Shoham, et al.
Kidney International|December 18, 2014
Obesity, metabolic health, and the risk of end-stage renal diseaseBhupesh Panwar, Lynae J Hanks, Rikki M Tanner, et al.
Pageof 21